Recently, Nanjing Normann chemiluminescenc platform NRM411-S7 and fluorescence platform NRM-FI-1000 obtained the FDA and CE dual certification. At this point, the company's main technology platform has been recognized by the world's authoritative institutions, further promoting the company's global development. Previously, the company has obtained nearly 200 CE certifications of nearly 200 projects such as Sars-Cov2 test kits, monkeypox virus test kits,chemiluminescence and fluorescence immunoassay projects.

The US Food and Drug Administration (FDA) is an authoritative institution of international medical review. Foods, drugs, cosmetics and medical devices certified by FDA certification are the global authoritative standards.

NRM411-S7 track-type small automatic 7-minutes chemiuminescence immunoassay analyzer has won the 2020 Jiangsu Provincial Science and Technology Progress Award for Science and Technology Progress for 7 minutes peripheral blood detection, especially suitable for integrated testing of fever and outpatient examination.

The NRM FI-1000 immunofluorescence quantitative analyzer is a precise POCT detection system. It has the characteristics of small size, high sensitivity, strong anti-interference, supporting reagents and detection samples.